Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Empowering Patients to Better Manage Diabetes Through Self-Care [Phase 3]
This Phase 3 trial assessed a self-care program for people with Type 1 or Type 2 diabetes; the study completed and results were posted in 20…
-
CLINICAL_TRIALS research · 2016-07-22Clinical Trial Update: Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
This clinical trial update describes a prospective cohort study (APT-2D) examining progression from pre-diabetes to type 2 diabetes, expande…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes [NA]
A completed clinical trial investigated quantitative in vivo biomarkers of oxidative stress in individuals with Type 2 diabetes mellitus, wi…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects [Phase 4]
Phase 4 trial evaluating the effect of albiglutide on gallbladder emptying in healthy subjects; results completed and posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-07-20Clinical Trial Update: A Survey To Elicit The Relationship Between Literacy And Glycemic Control In Pediatric Diabetes
The completed clinical trial surveyed pediatric diabetes patients to explore the relationship between health literacy and glycemic control.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Online Support for Diabetes Self-Management [NA]
A University of British Columbia-sponsored trial evaluating online support for diabetes self-management was terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028) [Phase 3]
Phase 3 trial update on the safety and efficacy of omarigliptin (MK-3102) in adults with type 2 diabetes and inadequate glycemic control; st…
-
CLINICAL_TRIALS trial_result · 2016-07-14Clinical Trial Update: Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus [Phase 4]
A completed Phase 4 trial compares mitiglinide versus acarbose in adults with Type 2 Diabetes Mellitus to assess efficacy and safety. The st…
-
CLINICAL_TRIALS withdrawal · 2016-07-13Clinical Trial Update: Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. [NA]
A clinical trial evaluating a nutritional supplement for people with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day [Phase 4]
A completed Phase 4 clinical trial update evaluating whether prandial treatment adjustment guided by continuous glucose monitoring improves …
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Low-level Laser Therapy in the Treatment of Chronic Periodontitis in Type 2 Diabetics [NA]
A completed clinical trial evaluated low-level laser therapy for treating chronic periodontitis in patients with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Genetics of Atherosclerosis in Mexican Americans
NHLBI-sponsored study on the genetics of atherosclerosis in Mexican Americans; status is COMPLETED. The study focused on cardiovascular cond…
-
CLINICAL_TRIALS research · 2016-07-12Clinical Trial Update: Evaluating the Impact of Year Long, Augmented Diabetes Self Management Support [NA]
An update on a year-long augmented diabetes self-management support trial for adults with type 2 diabetes, with status currently listed as u…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Interprofessional Community-Based Diabetes Intervention for Older Adults [NA]
A community-based interprofessional diabetes intervention trial for older adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) [Phase 1]
Phase 1 drug-drug interaction study of CKD-396 (CKD-396 DDI(A) P1) has completed, providing initial safety and pharmacokinetic interaction d…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes [NA]
This update notes the completed status of a clinical trial evaluating Proteus Discover in subjects with uncontrolled hypertension and type 2…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study [NA]
This is a completed clinical trial study update examining the molecular basis of healthy obesity and its relation to diabetes risk. The spon…
-
CLINICAL_TRIALS research · 2016-07-11Clinical Trial Update: Serum Sphingolipidomic Analyses in Healthy, Diabetic and Prediabetic Subjects
The document provides an update on a clinical trial that investigates serum sphingolipidomic profiles in healthy individuals, and in people …
-
FDA approval · 2016-07-11FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' metformin hydrochloride as an Original Application (ANDA) product. The approval makes a generic me…
-
FDA label_change · 2016-07-08FDA Approved: GLYXAMBI — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for GLYXAMBI (empagliflozin and linagliptin) to update its labeling.
-
FDA approval · 2016-07-08FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for SYNJARDY (empagliflozin and metformin hydrochloride) filed by Boehringer Ingelheim Pharmaceutica…
-
FDA approval · 2016-07-08FDA Approved: TRESIBA — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Tresiba (insulin degludec) from Novo Nordisk.
-
CLINICAL_TRIALS research · 2016-07-07Clinical Trial Update: The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers [Phase 1]
Phase 1 pharmacokinetics study of SP2086 administered as single and multiple doses in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications
An observational study update examining outcomes in type 2 diabetes patients who previously received long-term pioglitazone or placebo in ad…
-
CLINICAL_TRIALS trial_result · 2016-07-07Clinical Trial Update: Loop Duodenal Switch Surgery in Morbidly Obese Patients
The clinical trial evaluating loop duodenal switch surgery in morbidly obese patients with Type 2 Diabetes Mellitus has been terminated.